Ambulatory Blood Pressure Adds to Explaining Benefits of AT‐1 Receptor Blockade in the Treatment of Left Ventricular Hypertrophy
Year: 2007
Type: article
Abstract: Left ventricular hypertrophy (LVH) is a strong independent risk indicator of cardiovascular (CV) morbidity and mortality. The hypothesis of the Losartan Intervention For Endpoints in Hypertension (...
Source: Blood Pressure
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W1963913433
